UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
The New England journal of medicine, ISSN 0028-4793, 02/2019, Volume 380, Issue 8, pp. 791 - 793
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Sisomicin - therapeutic use | Humans | Bacteremia - drug therapy | Enterobacteriaceae Infections - mortality | Kaplan-Meier Estimate | Drug Resistance, Bacterial | Enterobacteriaceae Infections - complications | Healthcare-Associated Pneumonia - drug therapy | Sisomicin - analogs & derivatives | Anti-Bacterial Agents - therapeutic use | Carbapenem-Resistant Enterobacteriaceae | Sample Size | Intention to Treat Analysis | Creatinine - blood | Colistin - therapeutic use | Pneumonia, Bacterial - drug therapy | Enterobacteriaceae Infections - drug therapy | Pneumonia, Ventilator-Associated - drug therapy | Hypothesis testing | Ventilators | Pneumonia | Infections | Colistin | CRE bacteria | Index Medicus | Abridged Index Medicus
Journal Article
Seminars in dialysis, ISSN 0894-0959, 07/2016, Volume 29, Issue 4, pp. 309 - 311
Journal Article
The New England journal of medicine, ISSN 0028-4793, 02/2019, Volume 380, Issue 8, pp. 729 - 740
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Drug Administration Schedule | Administration, Oral | Humans | Middle Aged | Male | Meropenem - adverse effects | Meropenem - administration & dosage | Urinary Tract Infections - drug therapy | Microbial Sensitivity Tests | Patient Acuity | Sisomicin - administration & dosage | Sisomicin - analogs & derivatives | Administration, Intravenous | Drug Resistance, Multiple, Bacterial | Enterobacteriaceae - drug effects | Adult | Female | Urinary Tract Infections - microbiology | Aged | Anti-Bacterial Agents - adverse effects | Sisomicin - adverse effects | Anti-Bacterial Agents - administration & dosage | Enterobacteriaceae Infections - drug therapy | Urinary tract infections | Enterobacter | Research | Drug therapy | Risk factors | Enterobacteriaceae | Creatinine | Enzymes | Intravenous administration | Bacterial infections | Hospital costs | Research & development--R&D | Multidrug resistance | Body weight | Urinary tract | Drug resistance | Patients | Urology | Bactericidal activity | Urinary tract diseases | Intravenous therapy | Antibiotics | CRE bacteria | Pyelonephritis | Meropenem | Urogenital system | Index Medicus | Abridged Index Medicus
Journal Article
Kidney international, ISSN 0085-2538, 06/2018, Volume 93, Issue 6, pp. 1397 - 1408
alirocumab | PCSK9 | chronic kidney disease | impaired renal function | LDL-C | safety | Life Sciences & Biomedicine | Urology & Nephrology | Science & Technology | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Antibodies, Monoclonal - therapeutic use | Male | Renal Insufficiency, Chronic - complications | Hypercholesterolemia - drug therapy | Clinical Trials, Phase III as Topic | Cholesterol, LDL - blood | Female | Renal Insufficiency, Chronic - diagnosis | Drug Therapy, Combination | Kidney - physiopathology | Hypercholesterolemia - blood | Glomerular Filtration Rate | Down-Regulation | Risk Factors | Treatment Outcome | Biomarkers - blood | Proprotein Convertase 9 - metabolism | Renal Insufficiency, Chronic - physiopathology | Anticholesteremic Agents - adverse effects | Randomized Controlled Trials as Topic | Anticholesteremic Agents - therapeutic use | Proprotein Convertase 9 - antagonists & inhibitors | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Hypercholesterolemia - diagnosis | Hypercholesterolemia - complications | Aged | Hypertension | Lipoproteins (low density) | Renal function | Kidneys | Epidermal growth factor receptors | Lipids | Triglycerides | Low density lipoprotein | Cholesterol | Apolipoprotein B | Hypercholesterolemia | Kidney diseases | Safety | Cardiovascular diseases | Drug dosages | Statins | Index Medicus
Journal Article
Advances in chronic kidney disease, ISSN 1548-5595, 03/2019, Volume 26, Issue 2, pp. 87 - 91
Hypertension | Office blood pressure monitoring | Automated office blood pressure | CKD | Ambulatory blood pressure monitoring | Life Sciences & Biomedicine | Urology & Nephrology | Science & Technology | Automation | Sphygmomanometers | Humans | Blood Pressure Monitors | Blood Pressure Monitoring, Ambulatory - methods | Hypertension - therapy | Hypertension - diagnosis | Blood Pressure Determination - methods | Measurement | Blood pressure | Diagnosis | Health aspects | Methods | Index Medicus
Journal Article
Building services engineering research & technology, ISSN 0143-6244, 11/2017, Volume 38, Issue 6, pp. 635 - 649
domestic cold water service | volume flow rate | probability | domestic hot water service | loading unit | Domestic water service | oversizing | water | Technology | Construction & Building Technology | Science & Technology | Confidence intervals | Cold water | Cold | Buildings | Household wastes | Variations | Flow velocity | Materials selection | Engineers | Sizing | Empirical analysis | Cold flow
Journal Article
American journal of kidney diseases, ISSN 0272-6386, 2011, Volume 59, Issue 1, pp. 75 - 83
Nephrology | cardiovascular mortality | Type 2 diabetic nephropathy | Diabetes Mellitus Treatment for Renal Insufficiency Consortium (DIAMETRIC) | end-stage renal disease | RISK | UMCG Approved | TRIAL | GLOMERULAR-FILTRATION-RATE | AFRICAN-AMERICANS | OUTCOMES | CHRONIC KIDNEY-DISEASE | HYPERTENSIVE NEPHROSCLEROSIS | IRBESARTAN | EPIDEMIOLOGY | Life Sciences & Biomedicine | Urology & Nephrology | Science & Technology | Urinary tract. Prostate gland | Urinary system involvement in other diseases. Miscellaneous | Nephropathies. Renovascular diseases. Renal failure | Renal failure | Nephrology. Urinary tract diseases | Biological and medical sciences | Medical sciences | Cardiovascular Diseases - etiology | Humans | Middle Aged | Male | Incidence | Diabetic Nephropathies - complications | Kidney Failure, Chronic - epidemiology | Cardiovascular Diseases - mortality | Female | Retrospective Studies | Proteinuria - complications | Diabetes Mellitus, Type 2 - complications | Databases, Factual | Kidney Failure, Chronic - etiology | Index Medicus
Journal Article
American journal of kidney diseases, ISSN 0272-6386, 2014, Volume 64, Issue 5, pp. 714 - 722
Nephrology | diabetic kidney disease | kidney disease outcomes | Reduction of End Points in Non–Insulin-Dependent Diabetes With the Angiotensin II Antagonist Losartan (RENAAL) | Visit-to-visit variability in blood pressure | systolic blood pressure (SBP) | MORTALITY | Reduction of End Points in Non-Insulin-Dependent Diabetes With the Angiotensin II Antagonist Losartan (RENAAL) | ATHEROSCLEROSIS | RISK | MELLITUS | IMPACT | DISEASE | AFRICAN-AMERICANS | HYPERTENSION | ASSOCIATION | PROGRESSION | Reduction of End Points in NonInsulin-Dependent Diabetes With the Angiotensin II Antagonist Losartan (RENAAL) | Life Sciences & Biomedicine | Urology & Nephrology | Science & Technology | Diabetes. Impaired glucose tolerance | Kidneys | Urinary system involvement in other diseases. Miscellaneous | Nephrology. Urinary tract diseases | Biological and medical sciences | Endocrinopathies | Etiopathogenesis. Screening. Investigations. Target tissue resistance | Medical sciences | Endocrine pancreas. Apud cells (diseases) | Kidney - physiology | Prospective Studies | Tetrazoles - pharmacology | Follow-Up Studies | Angiotensin II Type 1 Receptor Blockers - therapeutic use | Cardiovascular Diseases - drug therapy | Humans | Middle Aged | Diabetic Nephropathies - drug therapy | Male | Diabetic Nephropathies - diagnosis | Angiotensin II Type 1 Receptor Blockers - pharmacology | Biphenyl Compounds - therapeutic use | Diabetic Nephropathies - physiopathology | Biphenyl Compounds - pharmacology | Female | Blood Pressure - drug effects | Blood Pressure - physiology | Cardiovascular Diseases - diagnosis | Cardiovascular Diseases - physiopathology | Kidney - drug effects | Double-Blind Method | Treatment Outcome | Office Visits - trends | Diabetes Mellitus, Type 2 - diagnosis | Diabetes Mellitus, Type 2 - physiopathology | Tetrazoles - therapeutic use | Aged | Diabetes Mellitus, Type 2 - drug therapy | Cohort Studies | Index Medicus
Journal Article
The New England journal of medicine, ISSN 0028-4793, 01/2021, Volume 384, Issue 2, pp. 129 - 139
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Sodium-Glucose Transporter 1 - antagonists & inhibitors | Sodium-Glucose Transporter 2 Inhibitors - therapeutic use | Sodium-Glucose Transporter 2 Inhibitors - adverse effects | Double-Blind Method | Humans | Middle Aged | Hospitalization - statistics & numerical data | Male | Renal Insufficiency, Chronic - complications | Diarrhea - chemically induced | Renal Insufficiency, Chronic - drug therapy | Cardiovascular Diseases - epidemiology | Cardiovascular Diseases - mortality | Female | Glycosides - adverse effects | Aged | Diabetes Mellitus, Type 2 - drug therapy | Mycoses - etiology | Diabetes Mellitus, Type 2 - complications | Glycosides - therapeutic use | Diabetic Ketoacidosis - chemically induced | Chronic kidney failure | Comorbidity | Patient outcomes | Hypoglycemic agents | Diabetes | Drug therapy | Testing | Heart failure | Myocardial infarction | Creatinine | Cerebral infarction | Heart attacks | Kidneys | Statistical analysis | Diarrhea | Hospitalization | Glucose | Patients | Risk factors | Glomerular filtration rate | Confidence intervals | Corporate sponsorship | Ketoacidosis | Hemoglobin | Kidney diseases | Cardiovascular diseases | Diabetes mellitus (non-insulin dependent) | Heart diseases | Index Medicus | Abridged Index Medicus
Journal Article
EMBO reports, ISSN 1469-221X, 06/2018, Volume 19, Issue 6, p. n/a
Journal Article
Clinical nephrology, ISSN 0301-0430, 2017, Volume 87, Issue 3, pp. 124 - 133
ESRD | Iron | Anemia | Ferritin | Life Sciences & Biomedicine | Urology & Nephrology | Science & Technology | Hematinics - therapeutic use | Humans | Middle Aged | Renal Dialysis - methods | Erythropoiesis - drug effects | Ferric Compounds - administration & dosage | Male | Hematinics - administration & dosage | Administration, Intravenous | Ferritins - blood | Ferric Compounds - therapeutic use | Phosphates - blood | Adult | Female | Aged
Journal Article
Diabetes (New York, N.Y.), ISSN 0012-1797, 06/2019, Volume 68, Issue Supplement 1, p. 236
Journal Article
JAMA internal medicine, ISSN 2168-6106, 12/2020, Volume 180, Issue 12, pp. 1655 - 1663
Journal Article